Lookup NU author(s): Fatmah Naemi,
Professor Simi Ali,
Professor John Kirby
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The presence of antibodies against class I human leukocyte antigens (HLA) can cause the development of chronic allograft rejection. Although endothelial cell activation has been identified as a main effector, the mechanisms mediating this process are not fully understood. Exposure of endothelium to antibodies against HLA antigens induces cell activation which promotes rejection. This activation process can be divided into two phases: an early response in which intracellular signalling proteins and transcription factors are activated, and a later change in protein expression and cell function. In this review, antibody-mediated endothelial signalling and the role of transcription factors in organ transplantation will be described with a particular focus on their potential to mediate some of the graft-damaging effects of anti-HLA class I antibodies. (C) 2011 Elsevier B.V. All rights reserved.
Author(s): Naemi FMA, Ali S, Kirby JA
Publication type: Article
Publication status: Published
Journal: Transplantation Immunology
Print publication date: 19/07/2011
ISSN (print): 0966-3274
ISSN (electronic): 1878-5492
Publisher: Elsevier BV
Altmetrics provided by Altmetric